General Dermatology

Palvella begins its phase 2 TOIVA trial of Qtorin rapamycin gel for cutaneous venous malformations, targeting the mTOR pathway.

While zinc deficiency shows strong ties to SD, researchers stated vitamin D's role is less clear and may depend on genetic factors.

By addressing skin health proactively, runners can enhance performance and longevity in the sport while minimizing discomfort and long-term dermatological damage.

Share your insights and anticipation with us.

The FDA recently proposed a new rule requiring standardized asbestos testing in talc-containing cosmetics to protect consumers from potential harm.

In case you missed it, this week we had news about a significant dual treatment approach for AD, organic filter-based sunscreens for sensitive skin, what we’re most looking forward to in 2025, and more.

Explore the top headlines of the week including 2025 PDUFA dates, 2024 interview insights, and awareness dates to add to your calendar.

After 8 weeks of use, the product showed improvements in skin sensitivity, transepidermal water loss, and skin corneum hydration.

We're welcoming 2025 with dermatology innovations, expert insights on chronic hand eczema, and new leadership at Dermatology Times.

Click here to view Dermatology Times' comprehensive list of health awareness days, months, weeks, and initiatives for 2025.

Experts in the field shared insights with Dermatology Times on what they're looking forward to most in the new year.

Dermatology Times is reviewing some of the most anticipated PDUFA dates of the upcoming year.

Explore the standout moments and expert insights from Dermatology Times' Cutaneous Connection podcast episodes in 2024.

Discover the most impactful insights and expert advice from Dermatology Times' 2024 Interview Intersection column.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies and clinical research from the year.

Find out what the top 10 most popular articles of 2024 were from Dermatology Times.

Catch up on coverage of FDA-approved drugs in the second half of 2024.

Explore the top dermatology news of 2024, highlighting breakthroughs, innovations, and key clinical insights shaping the future of skin care and treatment.

Catch up on coverage of FDA-approved drugs in the first half of 2024.

Dermatology Times is looking back on the top dermatology news headlines from 2024.

Dermatology Times is looking back on the top stories in dermatology that involve strides in skin health equity: addressing disparities for skin of color, women, LGBTQ+ patients, and improving care access.

These promising results align with what was discovered in the single-ascending dose portion of the trial earlier this year.

In case you missed it, this week we had news about tapinarof’s FDA approval in AD patients 2 and older, new ICD-10 codes for CCCA and FFA, a phase 2 study of INF904, and more.

Renata Block, MMS, PA-C; Ted Lain, MD, MBA, FAAD; Zoe Diana Draelos, MD; and Cheri Frey, MD, FAAD, bust common skin care myths in a Dermatology Times custom video series.

Dermatology Times is looking back on the top stories in dermatology from the month of December.